Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins (Q38967514)

8 September 2017

title

Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins (English)

1 reference

8 September 2017

0 references

0 references

Marco A De Bastiani

5

0 references

Richard B Parsons

object named as

Richard B Parsons

9

0 references

Flávio Kapczinski

6

object named as

Flávio Kapczinski

1 reference

José Alexandre de Souza Crippa

8 September 2017

7

object named as

José Alexandre S Crippa

1 reference

8 September 2017

10

Fábio Klamt

1 reference

8 September 2017

Patrícia Schönhofen

1

1 reference

8 September 2017

Liana M de Medeiros

2

1 reference

8 September 2017

Ivi Juliana Bristot

3

1 reference

8 September 2017

Fernanda M Lopes

4

1 reference

8 September 2017

Mauro Antônio A Castro

8

1 reference

8 September 2017

publication date

10 August 2014

1 reference

8 September 2017

published in

Molecular Neurobiology

1 reference

8 September 2017

volume

52

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

26-37

1 reference

Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

CB(1) cannabinoid receptors and their associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Optimization and validation of an alternative method to evaluate total reactive antioxidant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

21 January 2018

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Identification and classification of genes regulated by phosphatidylinositol 3-kinase- and TRKB-mediated signalling pathways during neuronal differentiation in two subtypes of the human neuroblastoma cell line SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

affy--analysis of Affymetrix GeneChip data at the probe level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Mitochondrial dysfunction in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Protective effect of tomatine against hydrogen peroxide-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Protective effects of cyclosativene on H2O 2-induced injury in cultured rat primary cerebral cortex cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Down-regulation of anandamide hydrolase in mouse uterus by sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

The emerging functions of endocannabinoid signaling during CNS development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Prenatal cannabis exposure and infant outcomes: overview of studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol in humans-the quest for therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

The acute effects of cannabinoids on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Synthetic cannabinoids: analysis and metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Isolation and structure of .DELTA. - tetrahydrocannabinol and other neutral cannabinoids from hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabinoids modulate cell survival in embryoid bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-014-8843-1

Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs

21 January 2018

1 reference

12 December 2020

Safety and side effects of cannabidiol, a Cannabis sativa constituent

1 reference

12 December 2020

Therapeutical use of the cannabinoids in psychiatry

1 reference

12 December 2020

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

1 reference

12 December 2020

Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements

1 reference

12 December 2020

Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader

1 reference

12 December 2020

10.1007/S12035-014-8843-1

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1033049982

0 references

1 reference